|
I.B. Zhurtova, A.M. Gubachikova, L.S. Aramisova, H.A. Abdul Moati, L.A. Anaeva
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
|
№12 / 2023
|
|
M.B. Antsiferov
Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№7 / 2012
|
|
A.Yu Mayorov, Ye.V. Surkova, I.I. Dedov
Assessment Of Efficacy Of Education Of General Practitioners By The Training Program For Management Of Type 2 Diabetes Mellitus
|
№16 / 2010
|
|
O.V. Zanozina
Possibility Of Correction Of Oxidative Stress In Patients With Diabetes Using Dibicor
|
№16 / 2010
|
|
A.V. Rudakova
Pharmacoeconomic Aspects Of Use Of Sulfonylurea Medications In Insulin-independent Diabetes
|
№16 / 2010
|
|
M.B. Antsiferov, L.Yu. Morgunov, N.A. Demidov, I.V. Volokitin
Potentials For Use Of Dipeptidyl Peptidase-4 Inhibitors In Type 2 Diabetes Mellitus: Initiation And Continuation Of Therapy
|
№16 / 2010
|
|
N.A. Petunina
When To Begin Combined Therapy Of Type 2 Diabetes Mellitus
|
№16 / 2010
|
|
Ye.V. Biryukova
Insulin Treatment Of Type 2 Diabetes Mellitus: A Choice And An Individual Approach
|
№16 / 2010
|
|
A.M. Mkrtumyan
Saxagliptin Opens New Opportunities For Effective And Safe Glycemic Control In Patients With Type 2 Diabetes Mellitus
|
№16 / 2010
|
|
T.Yu. Demidova
Etiopthogenic Role Of Insulin Resistance In The Development Of Metabolic And Vascular Disorders In Type 2 Diabetes Mellitus
|
№16 / 2010
|
|
M.B. Antsiferov, A.V. Zilov
Potentials For Use Of Dipeptidyl Peptidase-4 Inhibitors In Type 2 Diabetes Mellitus: Initiation And Continuation Of Therapy
|
№16 / 2010
|
|
N.Morkovskikh
Adiponectin And C-reactive Protein As Factors Of Cardiovascular Risk In Men With Type 2 Diabetes Mellitus
|
№8 / 2010
|
Русский
